Racial and ethnic differences in kidney function decline among persons without chronic kidney disease

Journal of the American Society of Nephrology

Volumn 22, Issue 7, 2011, Pages 1327-1334

  Peralta, Carmen A ^a   Katz, Ronit ^b   DeBoer, Ian ^c   Ix, Joachim ^d   Sarnak, Mark ^e   Kramer, Holly ^f   Siscovick, David ^b   Shea, Steven ^g   Szklo, Moyses ^h   Shlipak, Michael ^a,i  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^g Johns Hopkins Bloomberg School of Public Health ^*  (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHINESE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DISEASE COURSE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISPANIC; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 79960135935     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010090960     Document Type: Article

References (31)

1. USRDS: Renal Data System (USRDS) Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
2. Peralta CA, Shlipak MG, Fan D, Ordonez J, Lash JP, Chertow GM, Go AS: Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 17: 2892-2899, 2006
3. Hsu CY, Lin F, Vittinghoff E, Shlipak MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14: 2902-2907, 2003
4. Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS: The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68: 2310-2316, 2005
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
6. Powe NR: Reverse race and ethnic disparities in survival increase with severity of chronic kidney disease: What does this mean? Clin J Am Soc Nephrol 1: 905-906, 2006
7. Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranek EP: Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant 25: 801-807, 2010
8. Vupputuri S, Batuman V, Muntner P, Bazzano LA, Lefante JJ, Whelton PK, He J: Effect of blood pressure on early decline in kidney function among hypertensive men. Hypertension 42: 1144-1149, 2003
9. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278-285, 1985
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
12. Shlipak MG, Sarnak M, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen CO: Cystatin-C and risk for mortality and cardiovascular disease in elderly adults. N Engl J Med 352: 2049-2060, 2005
13. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145: 237-246, 2006
14. Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH: Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol 16: 1404-1412, 2005
15. Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G: Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 31: 971-973, 2008
16. McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, Cushman M, Howard G: Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 17: 1710-1715, 2006
17. Trivedi HS, Pang MM: Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: The third National Health and Nutrition Examination Survey and United States Renal Data System. Am J Nephrol 23: 448-457, 2003
18. Curhan GC: Prediabetes, prehypertension . . . is it time for pre-CKD? Clin J Am Soc Nephrol 5: 557-559, 2010
19. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192, 2008
20. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Knob AU, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
21. Roy B, Diez-Roux AV, Seeman T, Ranjit N, Shea S, Cushman M: Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom Med 72: 134-140, 2010
22. Day EC, Li Y, Diez Roux AV, Kandula N, Moran A, Rosas S, Shlipak MG, Peralta CA: Associations of acculturation and kidney dysfunction among Hispanics and Chinese from the Multi-Ethnic Study of Atherosclerosis (MESA). Nephrol Dial Transplant 2010, in press
23. Auchincloss AH, Diez Roux AV, Dvonch JT, Brown PL, Barr RG, Daviglus ML, Goff DC, Kaufman JD, O'Neill MS: Associations between recent exposure to ambient fine particulate matter and blood pressure in the Multi-ethnic Study of Atherosclerosis (MESA). Environ Health Perspect 116: 486-491, 2008
24. Norris K, Nissenson A: Racial disparities in chronic kidney disease: Tragedy, opportunity, or both? Clin J Am Soc Nephrol 3: 314-316, 2008
25. Prakash S, Rodriguez RA, Austin PC, Saskin R, Fernandez A, Moist LM, O'Hare AM: Racial composition of residential areas associates with access to pre-ESRD nephrology care. J Am Soc Nephrol 21: 1192-1199, 2010
26. Peralta CA, Li Y, Wassel C, Choudhry S, Palmas W, Seldin MF, Risch N, Siscovick D, Arnett D, Psaty B, Shlipak MG: Differences in albuminuria between Hispanics and whites: An evaluation by genetic ancestry and country of origin: The Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Genet 3: 240-247, 2010
27. Behar DM, Rosset S, Tzur S, Selig S, Yudkovsky G, Bercovici S, Kopp JB, Winkler CA, Nelson GW, Wasser WG, Skorecki K: African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet 19: 1816-1827, 2010
28. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S: Socioeconomic status in health research: One size does not fit all. JAMA 294: 2879-2888, 2005
29. Bild D, Bluemke DA, Burke G, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacobs DR Jr., Kronmal RA, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP: Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol 156: 871-881, 2002
30. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51: 395-406, 2008
31. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 38: 963-974, 1982